冀衡医药
(002742)
| 流通市值：19.59亿 | | | 总市值：25.59亿 |
| 流通股本：5.24亿 | | | 总股本：6.84亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 42,197,524.51 | 50,547,358.09 | 114,492,900.75 | 73,226,652.68 |
| 结算备付金 | - | - | 0 | - |
| 拆出资金 | - | - | 0 | - |
| 交易性金融资产 | - | - | 0 | - |
| 衍生金融资产 | - | - | 0 | - |
| 应收票据及应收账款 | 121,931,198.6 | 114,628,122.86 | 105,836,137.83 | 439,164,250.89 |
| 其中：应收票据 | - | - | 0 | 33,928,227.28 |
| 应收账款 | 121,931,198.6 | 114,628,122.86 | 105,836,137.83 | 405,236,023.61 |
| 应收款项融资 | 3,614,628.76 | 11,310,522.73 | 9,636,568.8 | 13,258,397.59 |
| 预付款项 | 4,836,034.21 | 3,521,935.64 | 3,367,282.21 | 199,742,011.6 |
| 应收保费 | - | - | 0 | - |
| 应收分保账款 | - | - | 0 | - |
| 应收分保合同准备金 | - | - | 0 | - |
| 其他应收款合计 | 532,460.79 | 419,521.19 | 344,392.6 | 7,800,241.58 |
| 存货 | 141,062,872.25 | 153,628,890.62 | 157,879,035.58 | 250,113,779.36 |
| 其他流动资产 | 3,447,276.14 | 3,203,930.76 | 1,941,210.34 | 5,861,446.25 |
| 流动资产合计 | 317,621,995.26 | 337,260,281.89 | 393,497,528.11 | 989,166,779.95 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 50,000 | 50,000 | 50,000 | 50,000 |
| 投资性房地产 | - | - | 0 | - |
| 固定资产 | 445,515,898.39 | 455,842,016.29 | 468,489,507.69 | 823,593,155.43 |
| 在建工程 | 4,065,119.62 | 1,908,874.16 | 1,306,594.27 | 20,896,739.69 |
| 生产性生物资产 | - | - | 0 | - |
| 油气资产 | - | - | 0 | - |
| 使用权资产 | - | - | 0 | - |
| 无形资产 | 130,491,806.49 | 131,843,043.35 | 132,509,646.23 | 239,784,848.66 |
| 开发支出 | - | - | 0 | - |
| 商誉 | 184,432,028.42 | 184,432,028.42 | 184,432,028.42 | 311,215,159.75 |
| 长期待摊费用 | 3,570,952.74 | 4,581,039.28 | 5,334,072.59 | 10,640,654.55 |
| 递延所得税资产 | 7,771,429.94 | 9,815,614.66 | 9,996,635.58 | 17,513,968.41 |
| 其他非流动资产 | 1,824,094.46 | 0 | 143,000 | 15,999,613.15 |
| 非流动资产合计 | 777,721,330.06 | 788,472,616.16 | 802,261,484.78 | 1,439,694,139.64 |
| 资产总计 | 1,095,343,325.32 | 1,125,732,898.05 | 1,195,759,012.89 | 2,428,860,919.59 |
| 流动负债: | | | | |
| 短期借款 | 7,721,207.92 | 57,721,207.92 | 57,324,248.55 | 617,929,132.88 |
| 向中央银行借款 | - | - | 0 | - |
| 吸收存款及同业存放 | - | - | 0 | - |
| 拆入资金 | - | - | 0 | - |
| 交易性金融负债 | - | - | 0 | - |
| 衍生金融负债 | - | - | 0 | - |
| 应付票据及应付账款 | 88,590,906.51 | 108,791,370.1 | 151,380,529.67 | 476,081,497.71 |
| 其中：应付票据 | - | - | 0 | - |
| 应付账款 | 88,590,906.51 | 108,791,370.1 | 151,380,529.67 | 476,081,497.71 |
| 预收款项 | 4,000 | - | 5,600 | - |
| 合同负债 | 21,455,359.24 | 21,086,560.97 | 19,154,718.04 | 77,409,101.07 |
| 卖出回购金融资产款 | - | - | 0 | - |
| 应付手续费及佣金 | - | - | 0 | - |
| 应付职工薪酬 | 5,003,738.9 | 5,134,826.95 | 15,584,883.86 | 46,344,370.42 |
| 应交税费 | 4,336,459.69 | 5,491,858.16 | 18,532,843.26 | 70,212,142.06 |
| 其他应付款合计 | 82,415,213.1 | 31,864,396.04 | 32,073,872.02 | 356,810,471.79 |
| 其中:应付利息 | 2,835,732.24 | 2,835,732.24 | 2,835,732.24 | - |
| 应付股利 | 26,000,000 | 26,000,000 | 26,000,000 | - |
| 代理买卖证券款 | - | - | 0 | - |
| 代理承销证券款 | - | - | 0 | - |
| 一年内到期的非流动负债 | 31,538,468.5 | 28,035,479.71 | 24,570,985.3 | 393,014,706.08 |
| 其他流动负债 | 1,957,255.14 | 2,330,685.48 | 2,415,354.45 | 801,198,187.41 |
| 流动负债合计 | 243,022,609 | 260,456,385.33 | 321,043,035.15 | 2,838,999,609.42 |
| 非流动负债: | | | | |
| 长期借款 | 444,206,654.36 | 444,206,654.36 | 444,206,654.36 | - |
| 预计负债 | - | - | - | 34,022,152 |
| 递延收益 | 54,000,992.46 | 54,938,728.05 | 55,672,713.66 | 54,744,544.46 |
| 其他非流动负债 | 135,539,363.51 | 135,539,363.51 | 135,539,363.51 | - |
| 非流动负债合计 | 633,747,010.33 | 634,684,745.92 | 635,418,731.53 | 88,766,696.46 |
| 负债合计 | 876,769,619.33 | 895,141,131.25 | 956,461,766.68 | 2,927,766,305.88 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 684,102,041 | 684,102,041 | 684,102,041 | 432,000,000 |
| 其他权益工具 | - | - | 0 | - |
| 优先股 | - | - | 0 | - |
| 永续债 | - | - | 0 | - |
| 资本公积 | 679,564,353.07 | 679,564,353.07 | 679,564,353.07 | 254,169,229.21 |
| 减:库存股 | - | - | 0 | - |
| 其他综合收益 | - | - | 0 | -351,066,855.2 |
| 专项储备 | - | - | 0 | 10,605,951.87 |
| 盈余公积 | 75,580,396.86 | 75,580,396.86 | 75,580,396.86 | 75,580,396.86 |
| 一般风险准备 | - | - | 0 | - |
| 未分配利润 | -1,291,004,703.65 | -1,278,939,523 | -1,270,866,246.73 | -1,028,931,686.23 |
| 归属于母公司股东权益合计 | 148,242,087.28 | 160,307,267.93 | 168,380,544.2 | -607,642,963.49 |
| 少数股东权益 | 70,331,618.71 | 70,284,498.87 | 70,916,702.01 | 108,737,577.2 |
| 股东权益合计 | 218,573,705.99 | 230,591,766.8 | 239,297,246.21 | -498,905,386.29 |
| 负债和股东权益合计 | 1,095,343,325.32 | 1,125,732,898.05 | 1,195,759,012.89 | 2,428,860,919.59 |
| 公告日期 | 2026-08-15 | 2026-04-25 | 2026-03-31 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |